OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Overall industry growth conceals growing numbers of smaller, faster-paced, adaptable corporate structures.
Unique solutions are required to protect inherently unstable messenger RNA.
Unique dosage forms, personalized medicine, and flexible manufacturing are possible with 3DP.
QMM provides industry with a viable methodology to assess and improve manufacturing quality and supply chain reliability.
PK/PD studies are a powerful tool for promoting successful biologic drug development.
Processing Equipment Trends
December 08, 2022
FDA struggles to track shortages caused by a rise in demand.
The most safe and effective therapies demand the highest data quality.
December 07, 2022
Ferring Pharmaceuticals’ Rebyota was approved for the prevention of recurrence of Clostridioides difficile infection.
The partnership will see the pharma giants partner with researchers from A*STAR and various Singapore universities.
In this episode of the Drug Solutions Podcast, Chris Spivey interviews executives at Shabbas Solutions LLC, who ran the overseas QMM pilot project.
Advances in contamination control are being to mitigate the presence of pollutants in drug products.
One can improve method precision and productivity by replacing one step in sample preparation with an automated approach.
Advancing digital transformation can significantly reduce R&D costs and shorten drug discovery timelines.
December 05, 2022
In addition, personnel, equipment, and facilities from the acquired companies will expand Reaction Biology’s presence in Germany while enabling its global customers to leverage Bioassay’s expansive portfolio of regulated clinical and commercial services.
December 03, 2022